Free Trial

Kronos Bio (KRON) Insider Trading & Ownership

Kronos Bio logo
$0.96 +0.03 (+3.21%)
(As of 12/20/2024 05:16 PM ET)

Kronos Bio (NASDAQ:KRON) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$2.79 M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$43,196.58
Get KRON Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kronos Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KRON Insider Buying and Selling by Quarter

Kronos Bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/27/2024Norbert W BischofbergerCEOBuy410,848$1.17$480,692.16  
6/12/2024Norbert W BischofbergerCEOBuy881,913$1.24$1,093,572.12  
6/10/2024Norbert W BischofbergerCEOBuy1,378,901$0.88$1,213,432.88  
2/21/2024Elizabeth A OlekSVPSell7,368$1.05$7,736.40  
1/4/2024Barbara KosaczCOOSell10,676$1.18$12,597.68  
1/4/2024Christopher DinsmoreInsiderSell7,366$1.18$8,691.88  
1/4/2024Jorge DimartinoVPSell12,009$1.18$14,170.62  
(Data available from 1/1/2013 forward)

KRON Insider Trading Activity - Frequently Asked Questions

The list of insiders at Kronos Bio includes Barbara Kosacz, Christopher Dinsmore, Elizabeth A Olek, Jorge Dimartino, Norbert W Bischofberger, and Yasir B Al-Wakeel. Learn more on insiders at KRON.

24.40% of Kronos Bio stock is owned by insiders. Learn more on KRON's insider holdings.

The following insider purchased KRON shares in the last 24 months: Norbert W Bischofberger ($3,990,017.36).

Insiders have purchased a total of 4,140,285 KRON shares in the last 24 months for a total of $3,990,017.36 bought.

The following insiders have sold KRON shares in the last 24 months: Barbara Kosacz ($12,597.68), Christopher Dinsmore ($44,289.32), Elizabeth A Olek ($7,736.40), Jorge Dimartino ($73,345.44), and Yasir B Al-Wakeel ($32,534.99).

Insiders have sold a total of 117,357 Kronos Bio shares in the last 24 months for a total of $170,503.83 sold.

Kronos Bio Key Executives

  • Dr. Norbert W. Bischofberger Ph.D.Dr. Norbert W. Bischofberger Ph.D. (Age 68)
    President, CEO & Director
    Compensation: $912.2k
    1 recent trades
  • Mr. Joshua A. Kazam (Age 47)
    Co-Founder & Director
    Compensation: $40k
  • Mr. David M. Tanen J.D. (Age 53)
    Secretary & Director
    Compensation: $40k
  • Ms. Sandra A. Gardiner (Age 58)
    Interim CFO & Principal Accounting Officer
  • Dr. Margaux Bennett Ph.D.
    Vice President of Corporate Development & Investor Relations
  • Ms. Allison Frisbee J.D. (Age 41)
    Senior Vice President of Corporate Operations & Legal
  • Dr. Charles Lin Ph.D. (Age 39)
    Senior Vice President of Research & Development
  • Dr. Elizabeth A. Olek D.O. (Age 59)
    M.P.H., Senior Vice President of Clinical Development
  • Mr. Wes Trotter Ph.D.
    Senior Vice President of Drug Discovery & Pharmaceutical Development
  • Ms. Rocio Martin Hoyos
    Senior Vice President of Corporate Strategy & Portfolio Management


This page (NASDAQ:KRON) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners